Advanced Search

Integrative Physiology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of James Bassingthwaighte

    James Bassingthwaighte

    Department of Bioengineering, University of Washington, Seattle, WA, USA

  • Photo of Mary Dallman

    Mary Dallman

    Department of Neuroscience, University of California, San Francisco, San Francisco, CA, USA

  • Photo of Yung Earm

    Yung Earm

    Seoul National University, Seoul, Korea, South

  • Photo of Randy Thomas

    Randy Thomas

    Department of Imagerie/ Echographie, Necker Faculty of Medicine, Paris, France

Section Topics

  • » Aging
  • » Biological clocks/chronophysiology
  • » Exercise & training
  • » Integrative renal physiology
  • » Neurohumoral regulation
  • » Physiological databasing/model databasing, archiving
  • » Regulation of breathing
  • » Regulation of cardiovascular system
  • » Systems biology
  • » Theoretical biology
  • » Transport physiology
  • » Vascular biology/physiology

LATEST EVALUATION

Sethumadhavan et al. derived and characterized two rat models of type 2 diabetes — both with comparable nuclear genomes but with different mitochondrial genomes. One strain, T2DNmtFFH, carries the mitochondrial genome of the Fawn Hooded...

Daniel Beard, Medical College of Wisconsin, USA. F1000 Physiology

6 Recommended

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

9
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists.

Solt LA, Wang Y, Banerjee S, Hughes T, ..., Takahashi JS, Butler AA, Kamenecka TM, Burris TP. Nature. 2012 Mar 29; 485:62-8

2 Evaluations, most recent by

David Mangelsdorf and Klementina Fon Tacer, University of Texas Southwestern Medical Center, USA. F1000 Cell Biology

  • New Finding
  • Confirmation
  • Novel Drug Target

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000